| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13149* | 2021 |
| Chk2 activates E2F-1 in response to DNA damage C Stevens, L Smith, NB La Thangue Nature cell biology 5 (5), 401-409, 2003 | 481 | 2003 |
| E2F and cell cycle control: a double-edged sword C Stevens, NB La Thangue Archives of biochemistry and biophysics 412 (2), 157-169, 2003 | 277 | 2003 |
| Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling E Sandilands, B Serrels, DG McEwan, JP Morton, JP Macagno, K McLeod, ... Nature cell biology 14 (1), 51-60, 2012 | 192 | 2012 |
| DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing B Harrison, M Kraus, L Burch, C Stevens, A Craig, P Gordon-Weeks, ... Journal of biological chemistry 283 (15), 9999-10014, 2008 | 161 | 2008 |
| The emerging role of E2F-1 in the DNA damage response and checkpoint control C Stevens, NB La Thangue DNA repair 3 (8-9), 1071-1079, 2004 | 160 | 2004 |
| Models of osteoarthritis: relevance and new insights HJ Samvelyan, D Hughes, C Stevens, KA Staines Calcified tissue international 109 (3), 243-256, 2021 | 133 | 2021 |
| Death‐associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death Y Lin, TR Hupp, C Stevens The FEBS journal 277 (1), 48-57, 2010 | 116 | 2010 |
| Death‐associated protein kinase (DAPK) and signal transduction: blebbing in programmed cell death M Bovellan, M Fritzsche, C Stevens, G Charras The FEBS journal 277 (1), 58-65, 2010 | 100 | 2010 |
| Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signaling C Stevens, Y Lin, B Harrison, L Burch, RA Ridgway, O Sansom, T Hupp Journal of Biological Chemistry 284 (1), 334-344, 2009 | 98 | 2009 |
| Inflammatory bowel disease drugs: a focus on autophagy KM Hooper, PG Barlow, C Stevens, P Henderson Journal of Crohn's and Colitis 11 (1), 118-127, 2017 | 93 | 2017 |
| Cathelicidins display conserved direct antiviral activity towards rhinovirus FH Sousa, V Casanova, F Findlay, C Stevens, P Svoboda, J Pohl, ... Peptides 95, 76-83, 2017 | 88 | 2017 |
| The intermediate filament protein, vimentin, is a regulator of NOD2 activity C Stevens, P Henderson, ER Nimmo, DC Soares, B Dogan, KW Simpson, ... Gut 62 (5), 695-707, 2013 | 85 | 2013 |
| Antiviral therapeutic approaches for human rhinovirus infections V Casanova, FH Sousa, C Stevens, PG Barlow Future virology 13 (07), 505-518, 2018 | 68 | 2018 |
| Autophagy: from basic science to clinical application J Van Limbergen, C Stevens, ER Nimmo, DC Wilson, J Satsangi Mucosal immunology 2 (4), 315-330, 2009 | 65 | 2009 |
| Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections F Findlay, L Proudfoot, C Stevens, PG Barlow Pathogens and Global Health 110 (4-5), 137-147, 2016 | 48 | 2016 |
| The role of autophagy in Crohn’s disease P Henderson, C Stevens Cells 1 (3), 492-519, 2012 | 46 | 2012 |
| Citrullination alters the antiviral and immunomodulatory activities of the human cathelicidin LL-37 during rhinovirus infection V Casanova, FH Sousa, P Shakamuri, P Svoboda, C Buch, M D'Acremont, ... Frontiers in immunology 11, 85, 2020 | 45 | 2020 |
| Identification of a dominant negative functional domain on DAPK-1 that degrades DAPK-1 protein and stimulates TNFR-1-mediated apoptosis Y Lin, C Stevens, T Hupp Journal of Biological Chemistry 282 (23), 16792-16802, 2007 | 42 | 2007 |
| A new role for E2F-1 in checkpoint control C Stevens, NBL Thangue Cell Cycle 2 (5), 434-436, 2003 | 40 | 2003 |
